Grad School Cost: MBA vs Law vs Medical ROI

A two-year MBA at Harvard Business School carries a 2025–26 cost of attendance of $126,536 per year — $253,072 before a single dollar of forgone income. That figure is the starting point, not the full picture. The real question for households earning $150k+ considering graduate school — for themselves or a child — is how many years of post-degree income it takes to recover the investment. The answer varies by 10 years or more depending on the degree chosen.

Key Numbers at a Glance

Sources: HBS, Stanford GSB, and Harvard Law official cost of attendance pages (2025–26); AAMC Tuition and Student Fees Reports (class of 2026); NALP Jobs & JDs Class of 2024 report; NALP 2025 Associate Salary Survey; GMAC Corporate Recruiters Survey 2024; AMN Healthcare 2025 Review of Physician and Advanced Practitioner Recruiting Incentives. *MD ratio uses attending salary as denominator but excludes 3–7 years of residency at $68,166/yr average (AAMC 2025 stipend survey) — see MD section for full time-adjusted analysis.

MBA: The Fastest Payback, the Widest Range

The two-year MBA is the shortest path on this list, and at top programs it also produces the most compressed payback window. Harvard Business School’s 2025–26 single-student cost of attendance is $126,536 per year, per the school’s official bursar data — up 6.5% from the prior year’s $118,854. Stanford GSB runs slightly higher at $135,771 annually, totaling $271,542 over two years. Wharton sits at $132,224 per year for 2025–26, according to F1GMAT’s analysis of institutional data, producing a two-year sticker of $264,448.

On the income side, the GMAC 2024 Corporate Recruiters Survey reported the U.S. MBA graduate median starting salary at $120,000. That number undersells elite program outcomes significantly. Among M7 programs — Harvard, Stanford, Wharton, Chicago Booth, Columbia, Kellogg, and MIT Sloan — Harvard, Wharton, Booth, and Columbia each reported a median starting salary of $175,000 for the Class of 2024, per Poets&Quants data. Stanford reported the highest average base salary at $187,504. The Wharton Class of 2025 median rose further to $185,000, according to Wharton’s own career report — the first increase since 2022.

Using HBS as the reference case: a 2-year total COA of $253,072 against a median M7 starting salary of $175,000 produces a Finluxy College Investment Ratio of 1.45 years. That clears the strong-ROI threshold of under 1.5 years. Outside the M7, the U.S. News data covering 133 ranked full-time programs found the overall average base salary plus bonus at $121,324 for Class of 2024 graduates. For a program running $200,000 in total COA and producing $121,324 in starting comp, the ratio jumps to 1.65 years — still reasonable, but the gap widens quickly as program rank declines.

The MBA’s ROI math also depends heavily on what you sacrifice to attend. Two years of foregone salary at a pre-MBA income of $120,000 adds another $240,000 to the true economic cost — a figure the sticker price never captures. Families evaluating this for a working professional should treat total opportunity cost as the relevant number, not just COA.

For $150k+ households funding this independently — likely without need-based aid at most programs, since MBA fellowships are heavily need-sensitive — the question shifts to liquidity planning. Stanford reports the average fellowship for the Class of 2025 at approximately $50,000 per year or $100,000 over two years for those demonstrating need. A household already at $150k typically will not demonstrate need at that level. The realistic funding path is full federal loan coverage, now complicated by the elimination of Grad PLUS loans after July 1, 2026 (per the Reconciliation Act of 2025). Students entering programs in fall 2026 face a new federal cap of $100,000 lifetime for graduate borrowers under the new rules — a gap that private lending will need to fill for programs costing $250,000+.

JD: The Most Bimodal Outcome in Graduate Education

No professional degree has a wider gap between best-case and median-case financial outcomes than the JD. The data on this point is unambiguous, and most law school marketing obscures it completely.

Harvard Law School’s 2025–26 cost of attendance is $117,382 per year for a single student, per CollegeTuitionCompare’s aggregation of Harvard’s bursar data — tuition at $78,692 plus living costs of $38,690. Over three years, sticker COA reaches $352,146. Columbia Law runs nearly identical at $119,944 per year, producing a three-year total of $359,832. The average total cost of law school (sticker) for the Class of 2026 across all ABA-accredited private programs was $198,788, according to EducationData.org’s analysis — meaning top-school costs run roughly 1.75 times the national average for private law schools.

The salary picture is where the analysis gets complicated. NALP’s Class of 2024 report — drawing on data from more than 97% of ABA-accredited graduates — found an overall median salary of $95,000, up 5.6% year-over-year. That median is almost meaningless as a planning figure because of how the distribution is shaped. Salary data for law graduates clusters in two distinct peaks: one in the $45,000–$80,000 range for government, nonprofit, public interest, and small-firm jobs, and another at $225,000 for large firms that have adopted the prevailing BigLaw scale.

Source: NALP Jobs & JDs: Employment and Salaries of New Law Graduates, Class of 2024 (released September 2025); NALP 2025 Associate Salary Survey (released May 2025).

Applied to Harvard Law’s three-year COA of $352,146: the Finluxy College Investment Ratio is 1.76 years on the BigLaw path ($352,146 ÷ $200,000 large-firm median) — within a reasonable range. But the non-BigLaw path produces a ratio of 3.71 years ($352,146 ÷ $95,000 overall median). The Cluster Brief’s risk threshold sits at 4.0 years, so that figure technically clears it — but it sits in the zone the brief describes as “financial risk depending on career certainty.” Career certainty in law is low; NALP found that only 32% of firms have adopted the $225,000 starting scale, meaning BigLaw placement is not guaranteed even from elite schools.

The overlooked dynamic in law school ROI analysis: the public law school option dramatically reframes this math. In-state graduates of the Class of 2026 paid an average of $165,854 for a law degree at public schools — a $186,000 discount versus Columbia or Harvard. If a public school graduate lands a firm job paying $200,000, their Investment Ratio drops to 0.83 years. The out-of-state tuition gap matters here too: public law school out-of-state students paid an average of $134,122 in tuition alone for their degree, still well below elite private options.

MD: The Strongest Long-Run Math, the Worst Short-Run Cash Flow

At the level of attending physician income, medical school generates some of the best ROI numbers in this comparison. The 2025 AMN Healthcare Physician Recruiting Incentives report puts the average starting physician salary at $403,000 across all specialties, with orthopedic surgery averaging $576,000 and family medicine at $275,000. Against average private medical school COA of $408,150 for four years (AAMC, class of 2026), the Finluxy College Investment Ratio at attending salary is 1.01 years. Public medical school at $297,745 drops that ratio to 0.74 years — the strongest score in this entire comparison.

Those ratios are technically accurate and practically misleading. The MD has a feature no MBA or JD carries: a mandatory multi-year delay between degree completion and attending income. After four years of medical school, physicians enter residency — a supervised training period that runs three years for primary care, five for general surgery, and seven or more for neurosurgery, cardiothoracic surgery, or orthopedics. During residency, the AAMC’s 2025 Survey of Resident/Fellow Stipends reports a PGY-1 national average stipend of $68,166 — often under $15 per hour when actual hours worked are factored in.

The cash-flow gap during residency is the figure most ROI analyses skip. A resident carrying $408,150 in medical school loans at a Grad PLUS rate of 8.94% (2025–26 rate, per the Department of Education) accumulates roughly $36,489 in annual interest during a standard three-year internal medicine residency while earning $68,166 per year. Total interest accrued across three residency years: approximately $109,467 — before repayment begins. Add that to the original $408,150 principal and the true cost of a private medical degree by the time of first attending paycheck is closer to $517,000. The Investment Ratio at that figure, against an average attending salary of $403,000, rises to 1.28 years — still strong, but the framing of “under 1 year” disappears entirely.

Specialty choice is the dominant variable. Against an orthopedic surgery starting offer of $576,000, even a $517,000 true cost yields a ratio of 0.90. Against pediatrics at $258,000, the same cost produces a ratio of 2.00 — and pediatrics residency itself runs three years, pushing the time-to-income window past a decade from matriculation.

Sources: AAMC Tuition and Student Fees Reports (class of 2026); AMN Healthcare 2025 Review of Physician and Advanced Practitioner Recruiting Incentives; AAMC 2025 Survey of Resident/Fellow Stipends and Benefits (PGY-1 average $68,166). Estimated true cost adds three years of interest at 8.94% Grad PLUS rate (2025–26) on private school COA during residency; five-year residency interest calculated at five years. True cost is an approximation using simple interest applied to principal; actual accrual under standard federal deferment may vary by loan mix. Starting salary figures are averages from AMN Healthcare data and will vary by market and negotiation.

An important structural change affects anyone entering medical school in fall 2026 or later. The Reconciliation Act of 2025 eliminated the Grad PLUS loan program effective July 1, 2026, and capped federal borrowing for professional students at $50,000 per year with a $200,000 lifetime aggregate. At virtually every private medical school — where COA exceeds $100,000 annually — this creates an annual gap of $55,000 to $65,000 per year, or $220,000 to $260,000 over four years that must be covered through private lending or family resources. For $150k+ households, this shifts the medical school financing conversation from loan strategy to direct family capital deployment, with private loan rates replacing the federal rate structure.

Finluxy College Investment Ratio: All Three Degrees Side by Side

The ratio calculations across degree types and school tiers reveal a pattern that cuts against the conventional wisdom that medicine is the safe financial bet and law is the risky one.

Finluxy College Investment Ratio = total net COA or estimated true cost ÷ reported starting salary. COA and true cost figures sourced as noted in prior sections. MBA COA based on HBS 2025–26 official data for M7 and U.S. News ranked program average for non-M7. JD COA based on Harvard Law 2025–26 official data and EducationData.org Class of 2026 public average. MD true cost adds estimated residency interest at 8.94% to AAMC class of 2026 COA averages. Salary sources: GMAC 2024, Poets&Quants Class of 2024 M7 data, NALP Class of 2024 and 2025 Associate Salary Survey, AMN Healthcare 2025.

The Insight Most Coverage Misses: Opportunity Cost Reverses the Rankings

Raw COA comparisons consistently understate the true cost of medical school and overstate the relative cost of the MBA. The reason: the MBA involves two years of foregone income; the MD involves four years of foregone income plus three to seven years of residency income suppression. A candidate earning $100,000 before graduate school sacrifices $200,000 in income during an MBA program. The same candidate, choosing medicine, sacrifices $400,000 in forgone pre-med income during medical school, then earns $68,166 for three or more residency years rather than the $100,000+ they would have earned in their prior career — an additional gap of roughly $32,000–$100,000 per year across residency.

Stack those opportunity costs against COA and the full economic cost of an MD from a private school — even before loan interest — can exceed $800,000 for someone leaving a $100,000 career. The attending salary is large enough to recover that. But the time horizon is 12 to 15 years from the day you start medical school to the day you reach peak attending income. Neither the MBA nor the JD carries that timeline. This is why the MD is simultaneously the best ratio on paper and the most demanding commitment in practice.

The most defensible frame for comparing degrees by ROI is not which degree has the lowest Investment Ratio at graduation — it is which degree produces the best risk-adjusted outcome given the candidate’s specific career probability. For law: what is the realistic probability of BigLaw placement from the specific school being considered? NALP found that only 84.3% of Class of 2024 graduates secured attorney positions at all, and BigLaw represents a fraction of that. The Ratio difference between the BigLaw (1.76) and non-BigLaw (3.71) paths for elite law school is large enough to treat law school financial planning as a probabilistic problem, not a deterministic one.

Loan Mechanics: What Funding These Degrees Actually Costs

For all three degrees funded primarily through borrowing, the 2025–26 federal interest rate environment is the relevant context. Direct Unsubsidized loans for graduate students carry a 7.94% fixed rate for 2025–26 disbursements; Grad PLUS loans carry 8.94%, per the Department of Education’s May 2025 announcement. Both rates are fixed for the life of loans disbursed in this window.

A $352,000 JD loan at 8.94% on a standard 10-year repayment schedule produces a monthly payment of approximately $4,360 and total interest of approximately $171,200 — nearly half the original principal again. For a deeper look at how loan repayment scales with debt size, the math compounds quickly at professional school balances.

The structural change arriving July 1, 2026 reshapes financing for incoming students entirely. Grad PLUS loans are eliminated under the Reconciliation Act of 2025. New professional students face a $50,000 annual federal cap and a $200,000 lifetime aggregate. At a medical school charging $102,000 per year in COA, that cap covers roughly half the annual bill. The other half requires private lending — at rates that are credit-dependent and not subject to income-driven repayment or Public Service Loan Forgiveness. This is the largest single change to graduate school financing in decades and has not yet been fully priced into how families are comparing program costs.

What This Means for $150k+ Households

At this income level, the financing calculus differs from lower-income households in three specific ways. First, need-based aid from graduate programs is minimal to nonexistent — Stanford GSB’s average fellowship of $100,000 over two years is need-tested, and a household at $150k+ is unlikely to qualify at meaningful levels. The financial aid reality at higher incomes for graduate programs mirrors what it is for undergraduate programs: largely irrelevant. Second, these households typically have the option of partially funding graduate school from liquid assets rather than through full borrowing — a choice that eliminates loan interest but has its own opportunity cost relative to keeping capital invested. Third, the decision about which degree to pursue intersects with existing household financial structure: a $150k+ household funding a child’s MD program faces the new $200,000 federal cap immediately, making family capital contribution not optional but mathematically necessary at private medical schools.

The comparison across degrees that most directly serves this income cohort: if the candidate is career-switching and likely to land in consulting or finance, the M7 MBA’s 1.45-year Investment Ratio represents genuinely strong economics. If law is the path, the school choice matters as much as the degree itself — the income outcome gap between prestigious and state school paths in law is more compressed than at the undergraduate level, making public law school an analytically strong choice. If medicine is the destination, the degree finances itself at scale, but the family should model the 12-year cash-flow timeline explicitly rather than relying on the headline attending salary number.

One more consideration families at this income level often overlook: undergraduate education debt stacking. A child who finishes four years at a private university at $70,000–$80,000 per year and then enters medical school is arriving at a $300,000–$400,000 graduate program carrying $100,000–$150,000 in undergraduate debt. The combined burden changes the Investment Ratio calculation materially. The Cluster Brief’s framework applies the ratio to the graduate degree in isolation — but the total student debt picture is what will actually determine whether the cash flow works in early career, particularly for residency-track physicians earning $68,166 annually while servicing six-figure loan balances.

For those actively planning at the undergraduate planning stage, the implications for 529 funding are direct. A 529 target built around an undergraduate COA may need to be recalibrated if professional school is a likely outcome — either to free up family capital for direct graduate school support or to ensure undergraduate costs are fully covered so the child enters professional programs debt-free, which changes the loan-funded portion dramatically. Separately, comparing the true net cost gap between public and private at the undergraduate level gains additional relevance when professional school is downstream: a child who attends a less expensive public university for four years arrives at law school or medical school with meaningfully more capacity to carry professional school debt.